Rigorous Research.
Reliable Results.

Clarity Science is a leading international scientific research organization that performs rigorous research in the field of healthcare across a myriad of therapeutic specialties.

We conduct institutional review board (IRB)-approved clinical research studies with the utmost integrity-- adhering to the highest standards of scientific excellence. Under the guidance of leading physicians, board-certified healthcare attorneys, and expert statisticians, our studies are producing reliable, informative outcomes. Our research has been well-received by healthcare providers and continues to be recognized at major national and international conferences.

Our goal is to conduct research that advances innovation in science and ultimately helps healthcare professionals provide treatments and improved patient care.

See informative results from our studies.

Current Scar Study

TARGET

(_Topic_Al Silicone in _Restorin_G Scars and Burn Tissue – _Evaluating _Therapy)

Positive interim TARGET Results have been presented at leading conferences, including the 7th Joint Meeting of the European Tissue Repair Society & the Wound Healing Society held in Copenhagen, Denmark, among others.

ETRS Wound-Healing-Society-Logo-BW

Results from an interim analysis of our TARGET study (a scar and burn treatment study) show that adults using a prescribed topical scar and burn cream reported:

Size
Reduced scar/burn size as measured by clinicians and as perceived by patients.
Itch
Reduced itching.
Mood
Reduced scar/burn interference with general activity, mood, sleep, and life enjoyment.
Pain_Meds
Reduced pain medication use.

VIEW TARGET POSTER SEE TARGET STUDY DETAILS

Closed Pain Study

OPERA

(_Optimizing _Patient _Experience and _Response to Topical _Analgesics)

Positive interim OPERA Results have been presented at important conferences, including the 4th Annual International Conference on Opioids held at Harvard Medical School, among others.

Opioidsharvard medical schoolACRPharvard medical school

Results from an interim analysis of our OPERA study (a pain study) show that patients with musculoskeletal and neuropathic pain using a prescribed topical analgesic reported:

Pain_Severity
Reduced pain severity for patients with neuropathic and musculoskeletal pain.
Daily_Activity
Reduced pain interference with general activity, mood, sleep, and life enjoyment.
Arthritis
Reduced number of primary pain complaints for arthritis, neuropathy, or radiculopathy.
OTC_Meds
Reduced use of over-the-counter medications, anti-inflammatory medications, and opioid analgesics.

VIEW OPERA POSTER SEE OPERA STUDY DETAILS

Conference & Publications Highlights

MORE CONFERENCES & PUBLICATIONS

News & Announcements

VISIT OUR NEWS PAGE